
The Weekly Roundup: June 27-July 1
ICYMI, this week we had stories about pediatric atopic dermatitis, managing complex diseases, Medicare, and more.
POLL: Which is the Most Common Skin Condition in the US?
What's New on Dermatology Times: June 27- July 1
Find out what the Dermatology Times Staff wrote about this week.
The Mainstream Patient: June 27
This week's edition of the Mainstream Patients features stories about FDA's latest approval, abortion, and more.
AMA Looks to Fight Back Against Health Professionals Spreading Misinformation
AMA has adopted a multi-prong strategy to try to counter lies while holding the person responsible to professional review.
Medicare Could Save Billions Buying Generics through Mark Cuban Prescription Drug Company
Entrepreneur beats prices of supply chain wholesalers, PBMs, pharmacies, and insurers.
FTC to Examine Drug Makers, PBMs Due to Insulin Prices
Rising insulin prices have led departments to examine the impetus behind setting prices that many patients can't afford.
Managing Complex Diseases with Therapeutic Monitoring Program
Complex diseases can be difficult to manage for optimal outcomes. Monitoring programs of therapies can help with that management.
Ready, Set, Go: Countdown to the Society for Pediatric Dermatology Conference
Lawrence Eichenfield, MD, is excited about the upcoming Society for Pediatric Dermatology Conference in Indianapolis July 7-10.
Report Finds Flaws in Medicare Race, Ethnicity Data
Errors impede efforts to overcome disparities in health care access and outcomes.
What's Trending in Skin Care: June 2022
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of June.
Pediatric Atopic Dermatitis: New Treatments and Therapies
Lawrence Eichenfield, MD, discusses new treatments and therapies for pediatric atopic dermatitis.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















